Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Keypoint Joins Datatrak's CRO Connect Program

Sat. May 09, 2009; Posted: 11:53 PM
Stocks RSS
May 01, 2009 (Close-Up Media via COMTEX) -- DTTK | Quote | Chart | News | PowerRating -- Datatrak International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, recenlty reported a multi-year agreement with the Portuguese CRO Keypoint - Consultoria cientifica, Lda.

As the newest member of Datatrak's CRO Connect Program, Keypoint is able to expand its electronic data capture (EDC) capabilities and empower its staff to more efficiently manage both its paper and EDC studies.

"Datatrak's eClinical is the platform that will give our customers a valuable solution on CDMS/EDC for clinical trials," said Keypoint CFO, Hugo Pedrosa. "We look at Datatrak not only as a solution provider but as a partner who will bring added value to our services."

"We welcome Keypoint as the newest member of the CRO Connect Program," said Datatrak CEO, Larry Birch. "Keypoint joins a growing list of CROs who are benefiting from our Datatrak eClinical platform, specialized pricing and joint marketing of the CRO Connect Program. We look forward to supporting Keypoint as they broaden their service offering and develop new revenue streams utilizing our platform."

Datatrak's CRO Connect Program is a collaborative initiative with CROs that offers the benefits of our comprehensive Datatrak eClinical solution through an innovative Enterprise Transfer program. The company said the program allows CROs to package their services around our eClinical platform in order to gain efficiencies and increased market share. The CRO Connect Program's flexible pricing and specialized consulting and professional services provides participants with the tools necessary to realize new growth opportunities.

Keypoint is a Portuguese CRO specializing in observational studies. To date, Keypoint noted, has collaborated in more than 150 observational studies, in Portugal, in all major therapeutic areas, including Oncology, Cardiology, Internal Medicine, CNS and Infectious Diseases.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

For full details for DTTK click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.